Departments of Otolaryngology-Head and Neck Surgery, University of Michigan, Ann Arbor, MI 48176, United States.
Departments of Otolaryngology-Head and Neck Surgery, University of Michigan, Ann Arbor, MI 48176, United States.
Oral Oncol. 2018 Dec;87:29-35. doi: 10.1016/j.oraloncology.2018.10.010. Epub 2018 Oct 22.
Disruption of E-cadherin function and increased expression of vimentin and the transcriptional oncogene, SOX2, are thought to characterize epithelial to mesenchymal transition (EMT) in HNSCC that contributes to invasive and metastatic behavior. To determine if such changes relate to prognosis or host immune response, expression of these markers and correlations with clinical characteristics, histologic worst pattern of invasion (WPOI) and tumor infiltrating lymphocytes (TIL) and survival were assessed.
Immunohistologic expression of markers was determined in tissue microarrays from 274 previously untreated HNSCC patients. Expression was correlated with levels of TILs in microcores and WPOI in biopsy specimens. Correlations were assessed by Kruskal-Wallis testing and Spearman correlation coefficients where appropriate. Overall and relapse-free survival were analyzed with Cox proportional hazards models. Median follow up was 60.0 months.
Loss of E-cadherin expression was significantly associated with low or absent SOX2 expression (R = 0.433, p < 0.0001). SOX2 expression and low grade WPOI were significantly associated with favorable overall (OS) and relapse free (RFS) survival in multivariable analysis. E-cadherin expression did not correlate with TILs, however WPOI score correlated indirectly with CD4, CD8, and FoxP3 levels. When grouped by primary treatment, lower grades (1, 2) of WPOI predicted improved RFS and OS in patients treated with primary surgery but not for patients treated with chemoradiation.
The findings suggest that SOX2 expression and WPOI are significant prognostic factors and that WPOI correlates with decreased T cell infiltration. The combination of markers and TILs might be useful in selecting patients for primary surgery.
E-钙黏蛋白功能的破坏和波形蛋白以及转录癌基因 SOX2 的表达增加被认为是 HNSCC 中上皮间质转化 (EMT) 的特征,这有助于侵袭和转移行为。为了确定这些变化是否与预后或宿主免疫反应有关,评估了这些标志物的表达及其与临床特征、组织学最差侵袭模式 (WPOI) 和肿瘤浸润淋巴细胞 (TIL) 以及生存的相关性。
在 274 例未经治疗的 HNSCC 患者的组织微阵列中测定了标志物的免疫组织化学表达。在微芯和活检标本中,评估了表达与 TIL 水平和 WPOI 的相关性。适当情况下,通过 Kruskal-Wallis 检验和 Spearman 相关系数评估相关性。使用 Cox 比例风险模型分析总生存期和无复发生存期。中位随访时间为 60.0 个月。
E-钙黏蛋白表达缺失与 SOX2 表达低或缺失显著相关(R=0.433,p<0.0001)。SOX2 表达和低级别 WPOI 在多变量分析中与总生存 (OS) 和无复发生存 (RFS) 显著相关。E-钙黏蛋白表达与 TIL 无相关性,但 WPOI 评分与 CD4、CD8 和 FoxP3 水平间接相关。按主要治疗分组,WPOI 分级较低(1 级和 2 级)预测接受手术治疗的患者的 RFS 和 OS 改善,但预测接受放化疗的患者的 RFS 和 OS 改善无统计学意义。
研究结果表明,SOX2 表达和 WPOI 是重要的预后因素,WPOI 与 T 细胞浸润减少相关。标志物和 TIL 的组合可能有助于选择接受手术治疗的患者。